SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001674796-17-000014
Filing Date
2017-11-20
Accepted
2017-11-20 14:00:51
Documents
38
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10-Q hstc10q3q2017.htm 10-Q 172396
2 EXHIBIT 31.1 exhibit311.htm EX-31 8209
3 EXHIBIT 31.2 exhibit312.htm EX-31 8193
4 EXHIBIT 32.1 exhibit321.htm EX-32 4469
5 EXHIBIT 32.2 exhibit322.htm EX-32 4503
  Complete submission text file 0001674796-17-000014.txt   757736

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hstc-20170930_cal.xml EX-101.CAL 14185
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hstc-20170930_def.xml EX-101.DEF 10263
8 XBRL INSTANCE DOCUMENT hstc-20170930.xml EX-101.INS 52579
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hstc-20170930_lab.xml EX-101.LAB 64425
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hstc-20170930_pre.xml EX-101.PRE 55572
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hstc-20170930.xsd EX-101.SCH 13774
Mailing Address 150 RESEARCH DR. HAMPTON VA 23666
Business Address 150 RESEARCH DR. HAMPTON VA 23666 757-766-6100
HST Global, Inc. (Filer) CIK: 0000797564 (see all company filings)

IRS No.: 731215433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15303 | Film No.: 171213422
SIC: 2834 Pharmaceutical Preparations